Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008 - A Swedish population-based study

International Journal of Cancer

Volumn 132, Issue 6, 2013, Pages 1429-1438

  Krynitz, Britta ^a,b   Edgren, Gustaf ^c   Lindelöf, Bernt ^b   Baecklund, Eva ^d   Brattström, Christina ^b   Wilczek, Henryk ^b   Smedby, Karin E ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

cancer risk; organ transplantation; population based study; skin cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART CANCER; HEART TRANSPLANTATION; HUMAN; KIDNEY CANCER; LIVER CANCER; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; SKIN CARCINOMA; STANDARDIZED INCIDENCE RATIO; SWEDEN;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; RISK; SKIN NEOPLASMS; SWEDEN;

EID: 84872949817     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27765     Document Type: Article

References (50)

1. Buell JF, Gross TG, Woodle ES,. Malignancy after transplantation. Transplantation 2005; 80: S254-64. (Pubitemid 41552912)
2. Engels EA, Pfeiffer RM, Fraumeni JF, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306: 1891-901.
3. Vajdic CM, van Leeuwen MT,. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009; 125: 1747-54.
4. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM,. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-Analysis. Lancet 2007; 370: 59-67. (Pubitemid 47017468)
5. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823-31. (Pubitemid 44969182)
6. Opelz G, Döhler B,. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004; 4: 222-30. (Pubitemid 38248525)
7. Hoffmann CJ, Subramanian AK, Cameron AM, et al. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation. Transplantation 2008; 86: 784-90.
8. Busnach G, Piselli P, Arbustini E, et al. Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals. Transplant Proc 2006; 38: 3533-5. (Pubitemid 44908520)
9. Euvrard S, Kanitakis J, Claudy A,. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-91. (Pubitemid 36459475)
10. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319: 1096-100. (Pubitemid 351300792)
11. Dubina M, Goldenberg G,. Viral-Associated nonmelanoma skin cancers: A review. Am J Dermatopathol 2009; 31: 561-73.
12. Schulz TF,. Cancer and viral infections in immunocompromised individuals. Int J Cancer 2009; 125: 1755-63.
13. Jensen P, Hansen S, Møller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-86. (Pubitemid 29072794)
14. Lindelöf B, Sigurgeirsson B, Gäbel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143: 513-9.
15. Adami J, Gäbel H, Lindelöf B, et al. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221-7. (Pubitemid 37363407)
16. Kyllönen L, Salmela K, Pukkala E,. Cancer incidence in a kidney-transplanted population. Transplant Int 2000; 13: S394-8.
17. Moloney FJ, Comber H, O'Lorcain P, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154: 498-504. (Pubitemid 43382659)
18. Villeneuve PJ, Schaubel DE, Fenton SS, et al. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2007; 7: 941-8. (Pubitemid 46481211)
19. Åberg F, Pukkala E, Hockerstedt K, et al. Risk of malignant neoplasms after liver transplantation: A population-based study. Liver Transplant 2008; 14: 1428-36.
20. Jiang Y, Villeneuve PJ, Fenton SS, et al. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study. Liver Transplant 2008; 14: 1588-97.
21. Jiang Y, Villeneuve PJ, Wielgosz A, et al. The incidence of cancer in a population-based cohort of Canadian heart transplant recipients. Am J Transplant 2010; 10: 637-45.
22. Collett D, Mumford L, Banner NR, et al. Comparison of the incidence of malignancy in recipients of different types of organ: A UK Registry audit. Am J Transplant 2010; 10: 1889-96.
23. Jensen AO, Svaerke C, Farkas D, et al. Skin cancer risk among solid organ recipients: A nationwide cohort study in Denmark. Acta Dermato-Venereologica 2010; 90: 474-9.
24. Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49: 506-9. (Pubitemid 20110465)
25. National Board of Health and Welfare CfE. In-patient diseases in Sweden 1987-2006, vol. 2012, 2007.
26. National Board of Health and Welfare CfE. Classification of Surgical Procedures Version 1.9, vol. 2012, 2004.
27. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11: 450.
28. National Board of Health and Welfare CfE. In English: The Swedish Cancer Register, vol. 2012, 2011.
29. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A,. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24: 659-67.
30. Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncologica 2009; 48: 27-33.
31. Fernberg P, Edgren G, Adami J, et al. Time trends in risk and risk determinants of non-hodgkin lymphoma in solid organ transplant recipients. Am J Transplant 2011; 11: 2472-82.
32. Simard JF, Baecklund E, Kinch A, et al. Pediatric organ transplantation and risk of premalignant and malignant tumors in Sweden. Am J Transplant 2011; 11: 146-51.
33. Ulm K,. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 1990; 131: 373-5. (Pubitemid 20118904)
34. Gjersvik P, Hansen S, Møller B, et al. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients? Transpl Int 2000; 13: S380-1.
35. Qian S, Thai NL, Fung JJ, et al. Liver transplant tolerance: mechanistic insights from animal models, with particular reference to the mouse. Transplant Rev 1997; 11: 151-64. (Pubitemid 127752218)
36. Attner P, Du J, Nasman A, et al. The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 2010; 126: 2879-84.
37. Kellerman L, Neugut A, Burke B, et al. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population. Am J Cardiol 2009; 103: 562-6.
38. Makitie AA, Lundberg M, Salmela K, et al. Head and neck cancer in renal transplant patients in Finland. Acta Oto-Laryngologica 2008; 128: 1255-8.
39. Brewer JD, Colegio OR, Phillips PK, et al. Incidence of and risk factors for skin cancer after heart transplant. Arch Dermatol 2009; 145: 1391-6.
40. Euvrard S, Kanitakis J, Decullier E, et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006; 81: 1093-100.
41. Liddington M, Richardson AJ, et al. Skin cancer in renal transplant recipients. Br J Surg 1989; 76: 1002-5. (Pubitemid 19251486)
42. Mackenzie KA, Wells JE, Lynn KL, et al. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients. Nephrol Dial Transplant 2010; 25: 300-6.
43. Wisgerhof HC, Edelbroek JR, de Fijter JW, et al. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors. Transplantation 2010; 89: 1231-8.
44. Lindelöf B, Jarnvik J, Ternesten-Bratel A, et al. Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: A study of the Swedish cohort. Acta Dermato Venereologica 2006; 86: 219-22. (Pubitemid 43875206)
45. Ingvar Å, Smedby KE, Lindelöf B, et al. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrol Dial Transplant 2010; 25: 2764-71.
46. Carucci J,. Basic scientific mechanisms of accelerated development of squamous cell carcinoma in organ transplant recipients. In:, Otely CC, Stasko, T, eds. Skin Disease in Organ Transplantation. New York: Cambridge University Press, 2008. 53-59.
47. Dinh QQ, Chong AH,. Melanoma in organ transplant recipients: the old enemy finds a new battleground. Austral J Dermatol 2007; 48: 199-207. (Pubitemid 47621737)
48. Dickson RP, Davis RD, Rea JB, et al. High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant 2006; 25: 1297-301. (Pubitemid 44692506)
49. Goh A, Vathsala A,. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am J Transplant 2011; 11: 86-92.
50. Karamchandani D, Arias-Amaya R, et al. Thyroid cancer and renal transplantation: A meta-Analysis. Endocr Rel Cancer 2010; 17: 159-67.